LONDON: Social media influencers in Germany and France were offered payment by a supposedly UK-based public relations firm to denounce the Pfizer coronavirus disease (COVID-19) vaccine.
Fazze, which claimed to have an address in London, reportedly urged influencers to tell their followers that the Pfizer jab was deadly and that regulators and the mainstream media were involved in a cover-up.
But when the targeted YouTubers and bloggers tried to find out more about Fazze the trail led to apparent Russian connections.
One influencer, Mirko Drotschmann, a German health commentator with 1.5 million YouTube subscribers, said that the PR agency had asked if he wanted to be part of an “information campaign” about Pfizer deaths in exchange for money. But after doing some research, he added: “Agency headquarters: London. Residence of the CEO: Moscow.”
US must do more to help global vaccination effort
arabnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabnews.com Daily Mail and Mail on Sunday newspapers.
Pharma Orgs Lay Out Vaccine Access Plan Without IP Waiver
law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.
Pharma Orgs Lay Out Vaccine Access Plan Without IP Waiver
law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.
(0)
TORONTO and CAMBRIDGE, Mass., May 19, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Neil Warma, MBA, to its Board of Directors with immediate effect. I am delighted to welcome Neil Warma as a member of the ProMIS Board of Directors at this time, said Eugene Williams, Executive Chairman of ProMIS Neurosciences. Neil s broad, international experience, coupled with a successful track record of executive leadership is a very welcome addition to the ProMIS Board.